帕金森病嗅觉丧失与认知的关联由纹状体多巴胺丢失和脑灌注介导
该回顾性研究分析343例新诊断帕金森病患者,使用CCSIT和双相18F-FP-CIT PET评估嗅觉、纹状体多巴胺转运体可用性和脑灌注。发现嗅觉评分与纹状体DAT可用性正相关,且嗅觉丧失通过后皮质低灌注和多巴胺丢失介导认知下降及痴呆转化风险。
要点
- 嗅觉评分与纹状体DAT可用性正相关,后壳核最强(β=0.21,P<0.001)。
- 低CCSIT评分预测基线认知更差和痴呆风险更高(HR=0.83,P=0.001)。
- 后皮质低灌注介导嗅觉-记忆关联,多巴胺丢失和低灌注共同介导痴呆转化。
核心结论
- 帕金森病嗅觉丧失反映涉及黑质纹状体和后皮质网络的广泛神经变性。
- 整合嗅觉评估与影像标志物可能更好识别认知下降风险患者。
研究设计与样本
- 回顾性分析343例新诊断帕金森病患者,均接受CCSIT和双相18F-FP-CIT PET。
- 早期PET作为局部脑血流灌注替代指标,晚期PET测量6个纹状体亚区DAT可用性。
- 219例患者完成基线神经心理测试并随访平均4.2年以评估痴呆转化。
主要发现
- 基线CCSIT评分与纹状体各区域DAT可用性正相关,后壳核最强(β=0.21,P<0.001)。
- 嗅觉减退与双侧内嗅、顶下、颞下和顶枕区皮质低灌注相关。
- 较低CCSIT评分预测基线认知表现更差(语言、记忆、执行功能;均P<0.05)和痴呆风险更高(HR=0.83,P=0.001)。
- 调整DAT和灌注标志物后,嗅觉与认知的直接关联显著减弱。
- 中介分析显示后皮质低灌注解释嗅觉-记忆关联,多巴胺丢失和低灌注共同介导痴呆转化。
临床怎么用
- 嗅觉评估联合18F-FP-CIT PET影像标志物可能改善帕金森病认知下降的风险分层。
- 对嗅觉丧失的帕金森病患者应关注认知衰退和痴呆转化风险,考虑早期干预。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 早期PET作为脑灌注替代指标,非直接血流测量。
- 仅219例完成神经心理测试和随访,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hyposmia is a common early non-motor symptom of Parkinson disease (PD) and has been linked to cognitive decline. This study investigated whether striatal dopaminergic degeneration and cerebral perfusion deficits mediate the relationship between hyposmia and cognition in PD. PATIENTS AND METHODS: We retrospectively analyzed 343 newly diagnosed PD patients who underwent the Cross-Cultural Smell Identification Test (CCSIT) and dual-phase 18 F-FP-CIT PET. Early-phase PET was used as a surrogate of regional cerebral blood perfusion, and late-phase PET measured dopamine transporter (DAT) availability in 6 striatal subregions. A subset of 219 patients completed baseline neuropsychological testing and were followed for a mean of 4.2 years to assess dementia conversion. RESULTS: Baseline CCSIT scores were positively correlated with DAT availability across striatal regions, strongest in the posterior putamen (β=0.21, P <0.001). Hyposmia was associated with cortical hypoperfusion in bilateral entorhinal, inferior parietal, inferior temporal, and parieto-occipital regions. Lower CCSIT scores predicted poorer baseline cognitive performance (language, memory, executive function; all P <0.05) and a higher risk of dementia (HR=0.83, P =0.001). In models adjusted for DAT and perfusion markers, direct associations between olfaction and cognition were markedly reduced. Mediation analyses revealed that posterior cortical hypoperfusion explained the olfaction-memory link, whereas both dopaminergic loss and hypoperfusion mediated dementia conversion. CONCLUSIONS: Olfactory loss in PD reflects widespread neurodegeneration involving nigrostriatal and posterior cortical networks. Integrating olfactory assessment with imaging markers may better identify patients at risk for cognitive decline, supporting improved risk stratification and early intervention.
引用
- Jeong SH, Kim SH, Park CW, et al. Association of Olfactory Loss With Cognition Is Mediated by Striatal Dopamine Loss and Cerebral Perfusion in Parkinson's Disease. Clin Nucl Med. 2026. PMID: 41738892. doi:10.1097/RLU.0000000000006387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。